1
|
Jordt SE, Jabba SV, Zettler PJ, Berman ML. Spree Bar, a vaping system delivering a synthetic nicotine analogue, marketed in the USA as 'PMTA exempt'. Tob Control 2024:tc-2023-058469. [PMID: 38499343 DOI: 10.1136/tc-2023-058469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Accepted: 03/06/2024] [Indexed: 03/20/2024]
Affiliation(s)
- Sven Eric Jordt
- Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
- Yale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
| | - Sairam V Jabba
- Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
- Yale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
| | - Patricia J Zettler
- College of Public Health, The Ohio State University, Columbus, Ohio, USA
- The Ohio State University Moritz College of Law, Columbus, Ohio, USA
| | - Micah L Berman
- College of Public Health, The Ohio State University, Columbus, Ohio, USA
- The Ohio State University Moritz College of Law, Columbus, Ohio, USA
| |
Collapse
|
2
|
Jordt SE, Jabba SV, Silinski P, Berman ML. An electronic cigarette pod system delivering 6-methyl nicotine, a synthetic nicotine analog, marketed in the United States as "PMTA exempt". MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2023:2023.11.21.23298778. [PMID: 38045384 PMCID: PMC10690343 DOI: 10.1101/2023.11.21.23298778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/05/2023]
Abstract
As of April 14, 2022, the United States Food and Drug Administration (FDA) has been authorized to regulate tobacco products containing nicotine from any source, including synthetic, requiring manufacturers to submit a premarket tobacco product application (PMTA). A recent report by the World Health Organization (WHO) warned that non-nicotine tobacco alkaloids or other synthetic nicotine analogs could be used by manufacturers to bypass regulatory schemes focusing on nicotine alone. From October 2023 on, vape stores in the United States started selling a new electronic cigarette pod system, named Spree Bar, advertised as "PMTA exempt", with youth-appealing flavors and advertising. The products are marketed as containing "Metatine", a trademarked name for 6-methyl nicotine, a synthetic nicotine analog patented by a Chinese electronic cigarette manufacturer. Here we used liquid chromatography-mass spectrometry (LCMS) to confirm the presence of a chemical species with the molecular weight of 6-methyl nicotine in Spree Bar e-liquids. The FDA needs to determine whether, in its view, 6-methyl nicotine is a form of "nicotine" within the meaning of the Tobacco Control Act, or whether 6-methyl nicotine can be regulated as a drug under the Federal Food, Drug, and Cosmetic Act (FDCA).
Collapse
Affiliation(s)
- Sven E Jordt
- Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
- Cancer Prevention and Control, Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA
- Yale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
| | - Sairam V Jabba
- Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
- Cancer Prevention and Control, Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA
- Yale Tobacco Center of Regulatory Science, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
| | | | - Micah L Berman
- College of Public Health, The Ohio State University, Columbus, Ohio, USA
- Moritz College of Law, The Ohio State University, Columbus, Ohio, USA
- Cancer Control Program, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA
| |
Collapse
|